Pyrimidinone compounds and pharmaceutical compositions containing them
US6417192B1 · kind B1 · utility
3Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2000 |
| Grant date | Jul 9, 2002 |
| Priority date | — |
| Expiry date | Jun 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A group of novel pyrimidone compounds are inhibitors of the enzyme LDL PLA2 and therefore of use in treating atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.